中重度术前贫血与经颈动脉血运重建患者术后心肌梗死及死亡率升高相关
基于血管质量倡议数据库(2016-2021)的回顾性分析纳入21648例经颈动脉血运重建(TCAR)患者,中重度术前贫血(女性Hb<10 g/dL、男性<11 g/dL)与院内MI、院内死亡及30天死亡率调整后比值显著升高相关,而轻度贫血未见类似关联,任何程度贫血均与术后卒中风险增加无关。
要点
- 中重度术前贫血与TCAR术后院内MI(aOR 2.39)、院内死亡(aOR 2.65)及30天死亡率(aOR 1.89)升高独立相关。
- 轻度贫血与不良术后结局风险增加无关,任何程度贫血均与术后卒中风险增加无关。
- 贫血严重程度与延长住院调整后比值呈阶梯式升高(轻度aOR 1.19,中重度aOR 1.57)。
核心结论
- 中重度术前贫血与TCAR术后院内MI、院内死亡及30天死亡率调整后比值升高独立相关,且不增加术后卒中风险。
- 中重度术前贫血可能是识别高危患者的潜在独立预后标志物,将贫血严重程度纳入术前风险分层可能有助于制定围术期心脏评估与优化策略。
研究设计与样本
- 回顾性分析血管质量倡议数据库(2016-2021)中因颈动脉狭窄行TCAR的患者。
- 共纳入21648例患者,按术前贫血有无及严重程度分为无贫血、轻度贫血和中重度贫血三组。
- 贫血按世界卫生组织指南定义:女性Hb<12 g/dL、男性Hb<13 g/dL;轻度为女性Hb 10-11.9 g/dL、男性Hb 11-12.9 g/dL;中重度为女性Hb<10 g/dL、男性<11 g/dL。
- 采用单因素和多因素logistic回归分析评估术前贫血严重程度与临床结局的关联。
主要发现
- 4240例(19.8%)有轻度贫血,3401例(15.8%)有中重度贫血。
- 与无贫血患者相比,中重度贫血患者院内MI的aOR为2.39(95%CI 1.53-3.74,P<0.001)。
- 与无贫血患者相比,中重度贫血患者院内死亡的aOR为2.65(95%CI 1.62-4.34,P<0.001)。
- 与无贫血患者相比,中重度贫血患者30天死亡率的aOR为1.89(95%CI 1.32-2.72,P<0.001)。
- 与无贫血队列相比,轻度贫血与不良术后结局风险增加无关;任何程度术前贫血均与TCAR术后卒中风险增加无关;贫血严重程度与延长住院调整后比值呈阶梯式升高(轻度aOR 1.19,中重度aOR 1.57)。
临床怎么用
- 作者认为,中重度术前贫血可能是识别TCAR高危患者的潜在独立预后标志物。
- 作者建议,将贫血严重程度纳入术前风险分层可能有助于制定围术期心脏评估与优化策略,从而可能降低TCAR术后不良结局风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While preoperative anemia is prevalent among surgical patients, its impact on patients undergoing transcarotid artery revascularization (TCAR) remains poorly understood. This study aims to assess the relationship between the severity of preoperative anemia and outcomes following TCAR. METHODS: A retrospective analysis of the Vascular Quality Initiative database (2016-2021) was performed to identify patients who underwent TCAR for carotid stenosis. Anemia was defined according to World Health Organization guidelines as a hemoglobin (Hb) level <12 g/dL in females and <13 g/dL in males. The severity of anemia was further classified as mild (Hb: 10-11.9 g/dL in females and 11-12.9 g/dL in males) or moderate to severe (Hb < 10 g/dL in females and <11 g/dL in males). Patients were stratified into three cohorts as follows, based on the presence and severity of preoperative anemia: no anemia, mild anemia, and moderate-to-severe anemia. The primary outcome was 30-day mortality. Secondary outcomes included in-hospital stroke, in-hospital death, myocardial infarction (MI), and prolonged postoperative hospitalization (>1 day). Univariable and multivariable logistic regression analyses were conducted to evaluate the association between the severity of preoperative anemia and clinical outcomes. RESULTS: Among 21,648 patients who underwent TCAR, 4,240 (19.8%) had mild anemia, and 3,401 (15.8%) had moderate-to-severe anemia preoperatively. After adjusting for relevant clinical factors and confounders, moderate-to-severe preoperative anemia was associated with significantly increased odds of in-hospital MI (adjusted odds ratio [aOR], 2.39; 95% confidence interval [CI]: 1.53-3.74; P < 0.001), in-hospital death (aOR, 2.65; 95% CI: 1.62-4.34; P < 0.001), and 30-day mortality (aOR, 1.89; 95% CI: 1.32-2.72; P < 0.001) compared to nonanemic patients. Among patients with moderate-to-severe anemia, factors such as a history of chronic obstructive pulmonary disease (COPD) or congestive heart failure (CHF), urgent or emergent procedures, and symptomatic carotid stenosis were the strongest predictors of 30-day mortality. In contrast, mild anemia was not associated with increased odds of adverse postoperative outcomes compared to the nonanemic cohort. Preoperative anemia, regardless of severity, was not associated with an increased risk of postoperative stroke following TCAR. However, the severity of preoperative anemia was associated with a stepwise increase in the adjusted odds of prolonged hospitalization (aOR, 1.19 [mild anemia] and 1.57 [moderate-to-severe anemia]). CONCLUSION: In this multi-institutional retrospective study of patients undergoing TCAR, moderate-to-severe preoperative anemia was independently associated with higher adjusted odds of in-hospital MI, in-hospital death, and 30-day mortality, without an increased risk of postoperative stroke. These findings highlight moderate-to-severe preoperative anemia as a potential independent prognostic marker for identifying high-risk patients. Furthermore, incorporating the severity of anemia into preoperative risk stratification may aid in tailoring perioperative cardiac assessment and optimization strategies, potentially mitigating the risk of adverse outcomes following TCAR.
引用
- Chang H, Garg K, Veith FJ, et al. Moderate-to-Severe Preoperative Anemia is Associated with Increased Postoperative Myocardial Infarction and Mortality in Patients Undergoing Transcarotid Artery Revascularization. Ann Vasc Surg. 2025. PMID: 40049547. doi:10.1016/j.avsg.2025.02.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。